pmc logo image
Assessment of Autoimmune Responses Associated with Asbestos Exposure in Libby, Montana, USA
Jean C. Pfau, Jami J. Sentissi, Greg Weller, and Elizabeth A. Putnam
Environ Health Perspect. 2005 January; 113(1): 25–30. Published online 2004 September 30. doi: 10.1289/ehp.7431.
PMCID: PMC1253705
 Is Cited by the Following Articles in this Archive:
Autoantibodies from mice exposed to Libby amphibole asbestos bind SSA/Ro52 – enriched apoptotic blebs of murine macrophages
David J. Blake, Scott A. Wetzel, and Jean C. Pfau
Toxicology. Author manuscript; available in PMC 2009 April 18.
PMCID: PMC2346587
Published in final edited form as: Toxicology. 2008 April 18; 246(2-3): 172–179. Published online 2008 January 19. doi: 10.1016/j.tox.2008.01.008.
Manuscript: | Abstract | Full Text | PDF–1.2M |
Asbestos: mining exposure, health effects and policy implications
Kristina Luus
Mcgill J Med. 2007 July; 10(2): 121–126.
PMCID: PMC2323486
Hyper-IgG4 disease: report and characterisation of a new disease
Guy H Neild, Manuel Rodriguez-Justo, Catherine Wall, and John O Connolly
BMC Med. 2006; 4: 23. Published online 2006 October 6. doi: 10.1186/1741-7015-4-23.
PMCID: PMC1618394
Nested Case–Control Study of Autoimmune Disease in an Asbestos-Exposed Population
Curtis W. Noonan, Jean C. Pfau, Theodore C. Larson, and Michael R. Spence
Environ Health Perspect. 2006 August; 114(8): 1243–1247. Published online 2006 May 30. doi: 10.1289/ehp.9203.
PMCID: PMC1551997